MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202641110413 A) filed by Ms Neutraparadigm Private Limited; and Ms. Sanjana Gogte on September 15, 2026, for Ai-Powered Multi-Omics Device For Gut-Metabolite Biomarker Detection And Personalized Nutraceutical Recommendation In Type 2 Diabetes.
Inventors include Dr. R. Devika Rubi; Mr. Niranjan Babu Bethi; Mr. Mudigonda Swaranjith; Mr. Sai Sathwik Reddy B; Mr. Kaipu Suryasrikar Reddy; Ms. Macha Samprithi Goud; and Mr. Mohammed Abdul Faisal.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: ABSTRACT “AI-POWERED MULTI-OMICS DEVICE FOR GUT-METABOLITE BIOMARKER DETECTION AND PERSONALIZED NUTRACEUTICAL RECOMMENDATION IN TYPE 2 DIABETES” relates to an AI-powered personalized device for gutmetabolite biomarker detection and precision nutraceutical supplementation in Type 2 Diabetes Mellitus (T2D). The device comprises a glucose biosensor and test strip, potentiostat, analog-to-digital converter, embedded processing unit, user data input interface, display unit, wireless communication interface and cloud-based database. The device acquires and processes blood glucose measurements and receives user-specific physiological information, gut microbiome data, gut metabolite data and blood metabolite data. An artificial intelligence-based biomarker analysis module integrates the received data to identify T2D-associated metabolic biomarkers, metabolite patterns and dysbiosis-associated signatures. A nutraceutical recommendation module correlates the identified biomarkers with naturally derived bioactive compounds and generates personalized nutraceutical supplement recommendations. The device thereby provides an integrated device for biomarker-guided gut metabolic assessment and personalized nutraceutical supplementation in Type 2 Diabetes. Refer
Disclaimer: Curated by HT Syndication.
